Drug recall · October 31, 2018
HydrOXYzine HYDROCHLORIDE SYRUP recall
Why: CGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
HydrOXYzine HYDROCHLORIDE SYRUP (HydrOXYzine Hydrochloride Oral Solution, USP), 10 mg per 5 mL, Rx only, Distributed by Lannett Company, Inc., Philadelphia, PA 19154, NDC 54838-502-80.
- Lots / codes
Lot #: 1097, Exp 10/18
- Quantity
- 8,324 bottles
- Company
- Lannett Company, Inc., Philadelphia, PA
- Distribution
- Nationwide in the USA
- Initiated
- October 11, 2018 · Voluntary: Firm initiated
- Classified
- October 19, 2018
- Reported
- October 31, 2018
- Ended
- February 22, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydroxyzine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.